- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05303025
Qualitative Research Among Physicians and Junior Doctors Into the Preconditions for Implementing a CDSS Based on AI in the ICU (KATRINA)
March 20, 2023 updated by: University Ghent
Qualitative Research Among Physicians and Junior Doctors Into the Preconditions for Implementing a Clinical Decision Support System (CDSS) Based on Artificial Intelligence (AI) in the ICU
The goal of this study is to explore the different attitudes and preconditions of potential end-users (doctors & physicians in training) required to achieve successful clinical implementation of models based on artificial intelligence (i.e. both machine learning and knowledge-driven techniques) as clinical decision support software.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
69
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aalst, Belgium
- OLV Aalst
-
Antwerpen, Belgium
- ZNA Ziekenhuizen
-
Ghent, Belgium
- Ghent University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Medical specialists or specialists in training working in intensive care at the time of the study.
Description
Inclusion Criteria:
- Medical specialist or specialist in training working in intensive care at the time of the study.
Exclusion Criteria:
- Age < 18 yo
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Baseline attitudes towards artificial intelligence and big data in medicine
Time Frame: baseline
|
Baseline attitudes towards artificial intelligence and big data in medicine will be collected through an online survey where participants will score their agreement with certain statements on a 6-point likert scale (Possible choices: Strongly agree - Agree - Neutral - Disagree - Totally Disagree - Not applicable).
|
baseline
|
|
Identify prerequisites that need to be fulfilled when AI/Big data based clinical decision support systems are used bedside from the viewpoint of the participants.
Time Frame: through study completion, an average of 1 year
|
Identify prerequisites that need to be fulfilled when AI/Big data based clinical decision support systems are used bedside and identify the most important ones for different aspects of the antimicrobial stewardship cycle from the viewpoint of the participants through a group discussion.
Reporting: frequencies.
|
through study completion, an average of 1 year
|
|
Identify subdomains of the antimicrobial stewardship cycle with potential for AI/Big data application
Time Frame: through study completion, an average of 1 year
|
Identify subdomains of the antimicrobial stewardship cycle for which participants think AI/Big data might be of use through a group discussion/interview. Reporting: frequencies.
|
through study completion, an average of 1 year
|
|
Identify perceived potential benefits and harms when applying AI in the antimicrobial stewardship cycle.
Time Frame: through study completion, an average of 1 year
|
Identify perceived potential benefits and harms when applying AI in the antimicrobial stewardship cycle through a group discussion.
Reporting: frequencies.
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subgroup analysis: age
Time Frame: through study completion, an average of 1 year
|
Explore if there are variations in the above mentioned outcomes when taking into account the age (years) of the participants.
|
through study completion, an average of 1 year
|
|
Subgroup analysis: gender
Time Frame: through study completion, an average of 1 year
|
Explore if there are variations in the above mentioned outcomes when taking into account the gender of the participants.
|
through study completion, an average of 1 year
|
|
Subgroup analysis: working environment (type of hospital, type of ICU)
Time Frame: through study completion, an average of 1 year
|
Explore if there are variations in the above mentioned outcomes when taking into account the working environment (University hospital vs non University hospital, small size hospital vs large size hospital, type of ICU (medical, surgery, mixed ICU, intermediate care)) - data which is collected in the baseline questionnaire) of the participants.
|
through study completion, an average of 1 year
|
|
Subgroup analysis: working experience (basic training and clinical experience).
Time Frame: through study completion, an average of 1 year
|
Explore if there are variations in the above mentioned outcomes when taking into account the working experience (type of basic training (anesthesiology, internal medicine, surgery, other), clinical experience (years) - data which is collected in the baseline questionnaire) of the participants.
|
through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jan De Waele, MD, PhD, University Ghent
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 13, 2022
Primary Completion (Actual)
October 31, 2022
Study Completion (Actual)
October 31, 2022
Study Registration Dates
First Submitted
February 22, 2022
First Submitted That Met QC Criteria
March 21, 2022
First Posted (Actual)
March 31, 2022
Study Record Updates
Last Update Posted (Actual)
March 22, 2023
Last Update Submitted That Met QC Criteria
March 20, 2023
Last Verified
October 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- BC-9892
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
If possible and feasible, anonymised survey data as well as transcript data from the group discussions will be made available on request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.